ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) is a biopharma firm with a portfolio that includes two commercial drugs. First, it has Nuplazid for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis (PDP). Secondly, ACAD has Daybue, which is indicated for Rett syndrome. These two IPsMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer sc ...